Cargando…

Longitudinal assessment of cardiac parameters through MRI in breast cancer patients treated with anti-HER2 therapy

BACKGROUND: We evaluated the early changes in left ventricular (LV) volumetric, functional, and tissue characteristics in human epidermal growth factor receptor 2 (HER2)-positive breast cancer patients treated with trastuzumab and/or pertuzumab at cardiac magnetic resonance imaging (MRI). METHODS: H...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Sainan, Wang, Jianwei, Wang, Yawen, Qi, Linlin, Li, Fenglan, Liu, Jianing, Chen, Jiaqi, Fan, Yang, Xie, Lizhi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Vienna 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183380/ https://www.ncbi.nlm.nih.gov/pubmed/37183212 http://dx.doi.org/10.1186/s41747-023-00338-9

Ejemplares similares

Diagnostic performance of a deep learning-based method in differentiating malignant from benign subcentimeter (≤10 mm) solid pulmonary nodules
por: Liu, Jianing, et al.
Publicado: (2023)

MRI-Based Radiomic Signature as a Prognostic Biomarker for HER2-Positive Invasive Breast Cancer Treated with NAC
por: Li, Qin, et al.
Publicado: (2020)

Optimal Duration of Neoadjuvant Taxane and Carboplatin Combined With Anti-HER2 Targeted Therapy for HER2-Positive Breast Cancer
por: Xie, Yifan, et al.
Publicado: (2021)

MRI-based radiomics value for predicting the survival of patients with locally advanced cervical squamous cell cancer treated with concurrent chemoradiotherapy
por: Zhang, Xiaomiao, et al.
Publicado: (2022)

Cardiac safety analysis of anti-HER2-targeted therapy in early breast cancer
por: Zhang, Li, et al.
Publicado: (2022)

Anti-Interleukin-16-Neutralizing Antibody Attenuates Cardiac Inflammation and Protects against Cardiac Injury in Doxorubicin-Treated Mice
por: Zhang, Jianwei, et al.
Publicado: (2021)

Echocardiographic and Cardiac MRI Comparison of Longitudinal Strain and Strain Rate in Cancer Patients Treated with Immune Checkpoint Inhibitors
por: Mirza, Jibran, et al.
Publicado: (2022)

Effect of long term CPAP therapy on cardiac parameters assessed with cardiac MRI
por: Wuest, W., et al.
Publicado: (2020)

Corrigendum to “Anti-Interleukin-16-Neutralizing Antibody Attenuates Cardiac Inflammation and Protects against Cardiac Injury in Doxorubicin-Treated Mice”
por: Zhang, Jianwei, et al.
Publicado: (2022)

Which cardiac parameters best predict the cardiovascular outcomes among patients with anti-PD-1 immunotherapy-induced myocardial injury?
por: Peng, Xiongjun, et al.
Publicado: (2022)

Prognostic value of different cardiac MRI parameters for the diagnosis of myocarditis
por: Ahmed, Waleed, et al.
Publicado: (2011)

Anti-HER-2 therapy following severe trastuzumab-induced cardiac toxicity
por: Sadek, Ibrahim, et al.
Publicado: (2017)

Correction to: Effect of long term CPAP therapy on cardiac parameters assessed with cardiac MRI
por: Wuest, W., et al.
Publicado: (2022)

Cardiac involvement in patients with primary biliary cholangitis: A 14-year longitudinal survey-based study
por: Bian, Sainan, et al.
Publicado: (2018)

Retrospective Electrocardiography-Gated Real-Time Cardiac Cine MRI at 3T: Comparison with Conventional Segmented Cine MRI
por: Cui, Chen, et al.
Publicado: (2019)

High HER2 protein levels correlate with increased survival in breast cancer patients treated with anti‐HER2 therapy
por: Nuciforo, Paolo, et al.
Publicado: (2015)

Combined Transcriptome and Metabolome Analysis Reveals Adaptive Defense Responses to DON Induction in Potato
por: Zhao, Biao, et al.
Publicado: (2023)

How to Follow, Manage and Treat Cardiac Dysfunction in Patients With Her2+ Breast Cancer
por: Blaes, Anne, et al.
Publicado: (2020)

EGFR, HER2, and HER3 protein expression in paired primary tumor and lymph node metastasis of colorectal cancer
por: Ye, Peng, et al.
Publicado: (2022)

Value of Machine Learning with Multiphases CE-MRI Radiomics for Early Prediction of Pathological Complete Response to Neoadjuvant Therapy in HER2-Positive Invasive Breast Cancer
por: Li, Qin, et al.
Publicado: (2021)

Longitudinal Changes in Echocardiographic Parameters of Cardiac Function in Pediatric Cancer Survivors
por: Border, William L., et al.
Publicado: (2020)

Cardiac safety of dual anti-HER2 blockade with pertuzumab plus trastuzumab in early HER2-positive breast cancer in the APHINITY trial
por: de Azambuja, E., et al.
Publicado: (2023)

Effectiveness of second-line anti-HER2 treatment in HER2-positive metastatic breast cancer patients previously treated with trastuzumab: A real-world study
por: Zhao, Wei, et al.
Publicado: (2020)

Echocardiographic parameters of systemic right ventricular size and function compared to cardiac MRI
por: Ruckdeschel, Emily, et al.
Publicado: (2014)

HER2/PD1 bispecific antibody in IgG4 subclass with superior anti‐tumour activities
por: Chu, Wendi, et al.
Publicado: (2022)

Effect of adjuvant trastuzumab among patients treated with anti-HER2-based neoadjuvant therapy
por: Gonzalez-Angulo, A M, et al.
Publicado: (2015)

Association of PIK3CA mutation with outcomes in HER2-positive breast cancer treated with anti-HER2 therapy: A meta-analysis and bioinformatic analysis of TCGA‑BRCA data
por: Chen, Haizhu, et al.
Publicado: (2023)

BioPATH: A Biomarker Study in Asian Patients with HER2+ Advanced Breast Cancer Treated with Lapatinib and Other Anti-HER2 Therapy
por: Kim, Sung-Bae, et al.
Publicado: (2019)

Texture Analysis Using Semiquantitative Kinetic Parameter Maps from DCE-MRI: Preoperative Prediction of HER2 Status in Breast Cancer
por: Song, Lirong, et al.
Publicado: (2021)

Patterns of HER2 Gene Amplification and Response to Anti-HER2 Therapies
por: Vicario, Rocio, et al.
Publicado: (2015)

HER2 heterogeneity and resistance to anti-HER2 antibody-drug conjugates
por: Ocaña, Alberto, et al.
Publicado: (2020)

Synthesis and functional studies of self-adjuvanting multicomponent anti-HER2 cancer vaccines
por: Feng, Qi, et al.
Publicado: (2021)

From Anti-HER-2 to Anti-HER-2-CAR-T Cells: An Evolutionary Immunotherapy Approach for Gastric Cancer
por: Sun, Jiangang, et al.
Publicado: (2022)

Enhanced Cardiac Testing in a Dual Anti-HER2 Regimen: What Have We Learned?
por: Ewer, Michael S., et al.
Publicado: (2016)

(131)I-Labeled Anti-HER2 Nanobody for Targeted Radionuclide Therapy of HER2-Positive Breast Cancer
por: Zhao, Lingzhou, et al.
Publicado: (2023)

Prognostic impact of body mass index (BMI) in HER2+ breast cancer treated with anti-HER2 therapies: from preclinical rationale to clinical implications
por: Ligorio, Francesca, et al.
Publicado: (2022)

Tumor-infiltrating lymphocytes predict prognosis of breast cancer patients treated with anti-Her-2 therapy
por: Chen, Tan-Huan, et al.
Publicado: (2016)

Mechanisms of resistance and sensitivity to anti-HER2 therapies in HER2+ breast cancer
por: de Melo Gagliato, Debora, et al.
Publicado: (2016)

Anti-HER2 Drugs for the Treatment of Advanced HER2 Positive Breast Cancer
por: Stanowicka-Grada, Malwina, et al.
Publicado: (2023)

Anti-Fibrotic Effects of Low Toxic Microcystin-RR on Bleomycin-Induced Pulmonary Fibrosis: A Comparison with Microcystin-LR
por: Wang, Jie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7qr4chr3svoo2lc0aggambc591